Gallacher Capital Management LLC

Position in LLY — ELI LILLY & Co

CIK 1960749 LONE TREE, CO

Position in LLY

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$638,096

+$64,160 QoQ

Shares Held

532

-14.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.63%

of 13F equity value

Holder Rank

#3,542

of 4,605 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Gallacher Capital Management LLC holds $3,790,927 across 9 Drug Manufacturers - General names. LLY ranks #1 (16.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	532	$638,096
2	NVS	Novartis AG	3,514	$550,714
3	NVO	Novo Nordisk A S	11,461	$549,440
4	JNJ	Johnson & Johnson	1,733	$440,130
5	GSK	GSK plc	8,312	$435,715
6	AZN	Astrazeneca PLC	2,120	$401,994
7	AMGN	Amgen Inc	797	$288,609
8	SNY	Sanofi	6,375	$271,957

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$638,096	532	-14.7%	Shares	Sole	2026-07-17
2026-03-31	$573,936	624	-59.9%	Shares	Sole	2026-05-06
2025-12-31	$1,671,127	1,555	+4.1%	Shares	Sole	2026-02-03
2025-09-30	$1,139,922	1,494	+87.7%	Shares	Sole	2025-11-05
2025-06-30	$620,505	796	+66.2%	Shares	Sole	2025-07-08
2025-03-31	$395,610	479	+23.8%	Shares	Sole	2025-05-05
2024-12-31	$298,764	387	-6.7%	Shares	Sole	2025-02-10
2024-09-30	$367,665	415	-1.4%	Shares	Sole	2024-11-12
2024-06-30	$381,164	421	0.0%	Shares	Sole	2024-08-06
2024-03-31	$327,521	421	-0.2%	Shares	Sole	2024-05-06
2023-12-31	$245,992	422	-0.9%	Shares	Sole	2024-02-06
2023-09-30	$228,817	426	-0.9%	Shares	Sole	2023-11-13
2023-06-30	$201,661	430	-27.2%	Shares	Sole	2023-08-11
2023-03-31	$202,961	591	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.